RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Journal:

Journal of Clinical Oncology

Published:

2025-07-09

DOI:

10.1200/jco-25-01346

Affiliations:

26

Authors:

29

Go to article

Institutions	Authors	Share
Replimune Inc., United States of America (USA)	5.000000	0.17
Institute Gustave-Roussy (IGR), France	2.000000	0.07
Holden Comprehensive Cancer Center, UI, United States of America (USA)	2.000000	0.07
NIHR Biomedical Research Centre for Cancer, United Kingdom (UK)	2.000000	0.07
USC Norris Comprehensive Cancer Center, United States of America (USA)	1.000000	0.03
UCLA Jonsson Comprehensive Cancer Center, United States of America (USA)	1.000000	0.03
Cincinnati Cancer Center, United States of America (USA)	1.000000	0.03
Banner MD Anderson Cancer Center, United States of America (USA)	1.000000	0.03
Cancer Research Center of Marseille (CRCM), France	1.000000	0.03
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.000000	0.03
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.03
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK)	1.000000	0.03
West Cancer Center, United States of America (USA)	1.000000	0.03
Churchill Hospital, United Kingdom (UK)	1.000000	0.03
University of Oxford, United Kingdom (UK)	1.000000	0.03
Roswell Park Cancer Institute (RPCI), United States of America (USA)	1.000000	0.03
Intermountain Medical Center, United States of America (USA)	1.000000	0.03
James Graham Brown Cancer Center, United States of America (USA)	1.000000	0.03
Duke University Health System, United States of America (USA)	1.000000	0.03
The Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom (UK)	0.500000	0.02
University of Liverpool, United Kingdom (UK)	0.500000	0.02
Human Immunology, Pathophysiology, Immunotherapy (HIPI), France	0.500000	0.02
Hôpital Saint-Louis, France	0.500000	0.02
National Center for Tumor Diseases West (NCT West), Germany	0.500000	0.02
University Alliance Ruhr (UA Ruhr), Germany	0.500000	0.02

Interested in Oncology and Carcinogenesis?